Pseudomonas Exotoxin A: Optimized by evolution for effective killing

Frontiers in Microbiology

Volumn 6, Issue SEP, 2015, Pages

  Michalska, Marta ^a   Wolf, Philipp ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

ADP ribosylation; Cytotoxic pathways; Pathoadaptation; Pseudomonas aeruginosa; Pseudomonas Exotoxin A; Virulence factor

Indexed keywords

IRON; PSEUDOMONAS EXOTOXIN; PSEUDOMONAS EXOTOXIN A; UNCLASSIFIED DRUG;

ADENOSINE DIPHOSPHATE RIBOSYLATION; APOPTOSIS; BACTERIAL COLONIZATION; ENDOSOME; GENE SEQUENCE; GLUCOSE METABOLISM; GLUCOSE OXIDATION; HUMAN; INTOXICATION; NONHUMAN; PROTEIN DEGRADATION; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; SHORT SURVEY; TRANS GOLGI NETWORK;

EID: 84946739228     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.00963     Document Type: Short Survey

References (64)

1. Abdel-Fattah, W., Scheidt, V., Uthman, S., Stark, M. J., and Schaffrath, R. (2013). Insights into diphthamide, key diphtheria toxin effector. Toxins (Basel) 5, 958-968. doi: 10.3390/toxins5050958
2. Armstrong, S., Li, J. H., Zhang, J., and Merrill, A. R. (2002). Characterization of competitive inhibitors for the transferase activity of Pseudomonas aeruginosa exotoxin A. J. Enzyme Inhib. Med. Chem. 17, 235-246. doi: 10.1080/1475636021000010914
3. Balasubramanian, D., Schneper, L., Kumari, H., and Mathee, K. (2013). A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence. Nucleic Acids Res. 41, 1-20. doi: 10.1093/nar/gks1039
4. Beattie, B. K., Prentice, G. A., and Merrill, A. R. (1996). Investigation into the catalytic role for the tryptophan residues within domain III of Pseudomonas aeruginosa exotoxin A. Biochemistry 35, 15134-15142. doi: 10.1021/bi961985t
5. Cancino, J., Jung, J. E., and Luini, A. (2013). Regulation of Golgi signaling and trafficking by the KDEL receptor. Histochem. Cell Biol. 140, 395-405. doi: 10.1007/s00418-013-1130-9
6. Chang, J. H., and Kwon, H. Y. (2007). Expression of 14-3-3delta, cdc2 and cyclin B proteins related to exotoxin A-induced apoptosis in HeLa S3 cells. Int. Immunopharmacol. 7, 1185-1191. doi: 10.1016/j.intimp.2007.05.001
7. Coggan, K. A., and Wolfgang, M. C. (2012). Global regulatory pathways and cross-talk control pseudomonas aeruginosa environmental lifestyle and virulence phenotype. Curr. Issues Mol. Biol. 14, 47-70.
8. Cornelis, P., and Dingemans, J. (2013). Pseudomonas aeruginosa adapts its iron uptake strategies in function of the type of infections. Front. Cell. Infect. Microbiol. 3:75. doi: 10.3389/fcimb.2013.00075
9. Daddaoua, A., Fillet, S., Fernandez, M., Udaondo, Z., Krell, T., and Ramos, J. L. (2012). Genes for carbon metabolism and the ToxA virulence factor in Pseudomonas aeruginosa are regulated through molecular interactions of PtxR and PtxS. PLoS ONE 7:e39390. doi: 10.1371/journal.pone.0039390
10. Daddaoua, A., Molina-Santiago, C., de la Torre, J., Krell, T., and Ramos, J. L. (2014). GtrS and GltR form a two-component system: the central role of 2-ketogluconate in the expression of exotoxin A and glucose catabolic enzymes in Pseudomonas aeruginosa. Nucleic Acids Res. 42, 7654-7663. doi: 10.1093/nar/gku496
11. Domenighini, M., and Rappuoli, R. (1996). Three conserved consensus sequences identify the NAD-binding site of ADP-ribosylating enzymes, expressed by eukaryotes, bacteria and T-even bacteriophages. Mol. Microbiol. 21, 667-674. doi: 10.1046/j.1365-2958.1996.321396.x
12. Douzi, B., Filloux, A., and Voulhoux, R. (2012). On the path to uncover the bacterial type II secretion system. Philos. Trans. R. Soc. Lond. B Biol. Sci. 367, 1059-1072. doi: 10.1098/rstb.2011.0204
13. Driscoll, J. A., Brody, S. L., and Kollef, M. H. (2007). The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs 67, 351-368. doi: 10.2165/00003495-200767030-00003
14. Du, X., Youle, R. J., FitzGerald, D. J., and Pastan, I. (2010). Pseudomonas exotoxin A-mediated apoptosis is Bak dependent and preceded by the degradation of Mcl-1. Mol. Cell. Biol. 30, 3444-3452. doi: 10.1128/MCB.00813-09
15. El Hage, T., Lorin, S., Decottignies, P., Djavaheri-Mergny, M., and Authier, F. (2010). Proteolysis of Pseudomonas exotoxin A within hepatic endosomes by cathepsins B and D produces fragments displaying in vitro ADP-ribosylating and apoptotic effects. FEBS J. 277, 3735-3749. doi: 10.1111/j.1742-4658.2010.07775.x
16. Farajnia, S., Peerayeh, S. N., Tanomand, A., Majidi, J., Goudarzi, G., Naghili, B., et al. (2015). Protective efficacy of recombinant exotoxin A-flagellin fusion protein against Pseudomonas aeruginosa infection. Can. J. Microbiol. 61, 60-64. doi: 10.1139/cjm-2014-0501
17. Gellatly, S. L., and Hancock, R. E. (2013). Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. Pathog. Dis. 67, 159-173. doi: 10.1111/2049-632X.12033
18. Gerard-Vincent, M., Robert, V., Ball, G., Bleves, S., Michel, G. P., Lazdunski, A., et al. (2002). Identification of XcpP domains that confer functionality and specificity to the Pseudomonas aeruginosa type II secretion apparatus. Mol. Microbiol. 44, 1651-1665. doi: 10.1046/j.1365-2958.2002.02991.x
19. Gomez, M. I., and Prince, A. (2007). Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis. Curr. Opin. Pharmacol. 7, 244-251. doi: 10.1016/j.coph.2006.12.005
20. Gordon, V. M., and Leppla, S. H. (1994). Proteolytic activation of bacterial toxins: role of bacterial and host cell proteases. Infect. Immun. 62, 333-340.
21. Gray, G. L., Smith, D. H., Baldridge, J. S., Harkins, R. N., Vasil, M. L., Chen, E. Y., et al. (1984). Cloning, nucleotide sequence, and expression in Escherichia coli of the exotoxin A structural gene of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U.S.A. 81, 2645-2649. doi: 10.1073/pnas.81.9.2645
22. Hazes, B., and Read, R. J. (1997). Accumulating evidence suggests that several AB-toxins subvert the endoplasmic reticulum-associated protein degradation pathway to enter target cells. Biochemistry 36, 11051-11054. doi: 10.1021/bi971383p
23. Hessler, J. L., and Kreitman, R. J. (1997). An early step in Pseudomonas exotoxin action is removal of the terminal lysine residue, which allows binding to the KDEL receptor. Biochemistry 36, 14577-14582. doi: 10.1021/bi971447w
24. Holm, A., and Vikstrom, E. (2014). Quorum sensing communication between bacteria and human cells: signals, targets, and functions. Front. Plant Sci. 5:309. doi: 10.3389/fpls.2014.00309
25. Hunt, T. A., Peng, W. T., Loubens, I., and Storey, D. G. (2002). The Pseudomonas aeruginosa alternative sigma factor PvdS controls exotoxin A expression and is expressed in lung infections associated with cystic fibrosis. Microbiology 148, 3183-3193. doi: 10.1099/00221287-148-10-3183
26. Iglewski, B. H., Liu, P. V., and Kabat, D. (1977). Mechanism of action of Pseudomonas aeruginosa exotoxin Aiadenosine diphosphate-ribosylation of mammalian elongation factor 2 in vitro and in vivo. Infect. Immun. 15, 138-144.
27. Jackson, M. E., Simpson, J. C., Girod, A., Pepperkok, R., Roberts, L. M., and Lord, J. M. (1999). The KDEL retrieval system is exploited by Pseudomonas exotoxin A, but not by Shiga-like toxin-1, during retrograde transport from the Golgi complex to the endoplasmic reticulum. J. Cell Sci. 112(Pt 4), 467-475.
28. Jenkins, C. E., Swiatoniowski, A., Issekutz, A. C., and Lin, T. J. (2004). Pseudomonas aeruginosa exotoxin A induces human mast cell apoptosis by a caspase-8 and-3-dependent mechanism. J. Biol. Chem. 279, 37201-37207. doi: 10.1074/jbc.M405594200
29. Jiang, M., Yao, J., and Feng, G. (2014). Protective effect of DNA vaccine encoding pseudomonas exotoxin A and PcrV against acute pulmonary P. aeruginosa Infection. PLoS ONE 9:e96609. doi: 10.1371/journal.pone.0096609
30. Jimenez, P. N., Koch, G., Thompson, J. A., Xavier, K. B., Cool, R. H., and Quax, W. J. (2012). The multiple signaling systems regulating virulence in Pseudomonas aeruginosa. Microbiol. Mol. Biol. Rev. 76, 46-65. doi: 10.1128/MMBR.05007-11
31. Jorgensen, R., Merrill, A. R., Yates, S. P., Marquez, V. E., Schwan, A. L., Boesen, T., et al. (2005). Exotoxin A-eEF2 complex structure indicates ADP ribosylation by ribosome mimicry. Nature 436, 979-984. doi: 10.1038/nature03871
32. Koopmann, J. O., Albring, J., Huter, E., Bulbuc, N., Spee, P., Neefjes, J., et al. (2000). Export of antigenic peptides from the endoplasmic reticulum intersects with retrograde protein translocation through the Sec61p channel. Immunity 13, 117-127. doi: 10.1016/S1074-7613(00)00013-3
33. Kounnas, M. Z., Morris, R. E., Thompson, M. R., FitzGerald, D. J., Strickland, D. K., and Saelinger, C. B. (1992). The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A. J. Biol. Chem. 267, 12420-12423.
34. Kreitman, R. J., and Pastan, I. (1995). Importance of the glutamate residue of KDEL in increasing the cytotoxicity of Pseudomonas exotoxin derivatives and for increased binding to the KDEL receptor. Biochem. J. 307(Pt 1), 29-37. doi: 10.1042/bj3070029
35. Lamont, I. L., Beare, P. A., Ochsner, U., Vasil, A. I., and Vasil, M. L. (2002). Siderophore-mediated signaling regulates virulence factor production in Pseudomonasaeruginosa. Proc. Natl. Acad. Sci. U.S.A. 99, 7072-7077. doi: 10.1073/pnas.092016999
36. Li, M., Dyda, F., Benhar, I., Pastan, I., and Davies, D. R. (1996). Crystal structure of the catalytic domain of Pseudomonas exotoxin A complexed with a nicotinamide adenine dinucleotide analog: implications for the activation process and for ADP ribosylation. Proc. Natl. Acad. Sci. U.S.A. 93, 6902-6906. doi: 10.1073/pnas.93.14.6902
37. Liu, P. V. (1974). Extracellular toxins of Pseudomonas aeruginosa. J. Infect. Dis. 130(Suppl.), S94-S99. doi: 10.1093/infdis/130.Supplement.S94
38. Lu, H. M., Mizushima, S., and Lory, S. (1993). A periplasmic intermediate in the extracellular secretion pathway of Pseudomonas aeruginosa exotoxin A. J. Bacteriol. 175, 7463-7467.
39. Marvig, R. L., Sommer, L. M., Molin, S., and Johansen, H. K. (2015). Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis. Nat. Genet. 47, 57-64. doi: 10.1038/ng.3148
40. Maschmeyer, G., and Braveny, I. (2000). Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990s. Eur. J. Clin. Microbiol. Infect. Dis. 19, 915-925. doi: 10.1007/s100960000410
41. McKee, M. L., and FitzGerald, D. J. (1999). Reduction of furin-nicked Pseudomonas exotoxin A: an unfolding story. Biochemistry 38, 16507-16513. doi: 10.1021/bi991308+
42. Nguyen, D., and Singh, P. K. (2006). Evolving stealth: genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections. Proc. Natl. Acad. Sci. U.S.A. 103, 8305-8306. doi: 10.1073/pnas.0602526103
43. Odumosu, O., Nicholas, D., Yano, H., and Langridge, W. (2010). AB toxins: a paradigm switch from deadly to desirable. Toxins (Basel) 2, 1612-1645. doi: 10.3390/toxins2071612
44. Ogata, M., Chaudhary, V. K., Pastan, I., and FitzGerald, D. J. (1990). Processing of Pseudomonas exotoxin by a cellular protease results in the generation of a 37,000-Da toxin fragment that is translocated to the cytosol. J. Biol. Chem. 265, 20678-20685.
45. Ogata, M., Fryling, C. M., Pastan, I., and FitzGerald, D. J. (1992). Cell-mediated cleavage of Pseudomonas exotoxin between Arg279 and Gly280 generates the enzymatically active fragment which translocates to the cytosol. J. Biol. Chem. 267, 25396-25401.
46. Ortiz, P. A., and Kinzy, T. G. (2005). Dominant-negative mutant phenotypes and the regulation of translation elongation factor 2 levels in yeast. Nucleic Acids Res. 33, 5740-5748. doi: 10.1093/nar/gki882
47. Pelham, H. R., Roberts, L. M., and Lord, J. M. (1992). Toxin entry: how reversible is the secretory pathway? Trends Cell Biol. 2, 183-185. doi: 10.1016/0962-8924(92)90230-K
48. Pirnay, J. P., Bilocq, F., Pot, B., Cornelis, P., Zizi, M., Van Eldere, J., et al. (2009). Pseudomonas aeruginosa population structure revisited. PLoS ONE 4:e7740. doi: 10.1371/journal.pone.0007740
49. Proud, C. G. (1994). Peptide-chain elongation in eukaryotes. Mol. Biol. Rep. 19, 161-170. doi: 10.1007/BF00986958
50. Rowe, S. M., Miller, S., and Sorscher, E. J. (2005). Cystic fibrosis. N. Engl. J. Med. 352, 1992-2001. doi: 10.1056/NEJMra043184
51. Siegall, C. B., Chaudhary, V. K., FitzGerald, D. J., and Pastan, I. (1989). Functional analysis of domains II, Ib, and III of Pseudomonas exotoxin. J. Biol. Chem. 264, 14256-14261.
52. Smith, D. C., Spooner, R. A., Watson, P. D., Murray, J. L., Hodge, T. W., Amessou, M., et al. (2006). Internalized Pseudomonas exotoxin A can exploit multiple pathways to reach the endoplasmic reticulum. Traffic 7, 379-393. doi: 10.1111/j.1600-0854.2006.00391.x
53. Su, S., and Hassett, D. J. (2012). Anaerobic Pseudomonas aeruginosa and other obligately anaerobic bacterial biofilms growing in the thick airway mucus of chronically infected cystic fibrosis patients: an emerging paradigm or "Old Hat?" Expert Opin. Ther. Targets 16, 859-873. doi: 10.1517/14728222.2012.708025
54. Su, X., Lin, Z., and Lin, H. (2013). The biosynthesis and biological function of diphthamide. Crit. Rev. Biochem. Mol. Biol. 48, 515-521. doi: 10.3109/10409238.2013.831023
55. Tafesse, F. G., Guimaraes, C. P., Maruyama, T., Carette, J. E., Lory, S., Brummelkamp, T. R., et al. (2014). GPR107, a G-protein-coupled receptor essential for intoxication by Pseudomonas aeruginosa exotoxin A, localizes to the Golgi and is cleaved by furin. J. Biol. Chem. 289, 24005-24018. doi: 10.1074/jbc.M114.589275
56. Theuer, C. P., Buchner, J., FitzGerald, D., and Pastan, I. (1993). The N-terminal region of the 37-kDa translocated fragment of Pseudomonas exotoxin A aborts translocation by promoting its own export after microsomal membrane insertion. Proc. Natl. Acad. Sci. U.S.A. 90, 7774-7778. doi: 10.1073/pnas.90.16.7774
57. Voulhoux, R., Taupiac, M. P., Czjzek, M., Beaumelle, B., and Filloux, A. (2000). Influence of deletions within domain II of exotoxin A on its extracellular secretion from Pseudomonas aeruginosa. J. Bacteriol. 182, 4051-4058. doi: 10.1128/JB.182.14.4051-4058.2000
58. Wedekind, J. E., Trame, C. B., Dorywalska, M., Koehl, P., Raschke, T. M., McKee, M., et al. (2001). Refined crystallographic structure of Pseudomonas aeruginosa exotoxin A and its implications for the molecular mechanism of toxicity. J. Mol. Biol. 314, 823-837. doi: 10.1006/jmbi.2001.5195
59. Weidle, U. H., Tiefenthaler, G., Schiller, C., Weiss, E. H., Georges, G., and Brinkmann, U. (2014). Prospects of bacterial and plant protein-based immunotoxins for treatment of cancer. Cancer Genomics Proteomics 11, 25-38.
60. White, J., Johannes, L., Mallard, F., Girod, A., Grill, S., Reinsch, S., et al. (1999). Rab6 coordinates a novel Golgi to ER retrograde transport pathway in live cells. J. Cell Biol. 147, 743-760. doi: 10.1083/jcb.147.4.743
61. Wiehlmann, L., Wagner, G., Cramer, N., Siebert, B., Gudowius, P., Morales, G., et al. (2007). Population structure of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U.S.A. 104, 8101-8106. doi: 10.1073/pnas.0609213104
62. Wolf, P., and Elsasser-Beile, U. (2009). Pseudomonas exotoxin A: from virulence factor to anti-cancer agent. Int. J. Med. Microbiol. 299, 161-176. doi: 10.1016/j.ijmm.2008.08.003
63. Yates, S. P., and Merrill, A. R. (2004). Elucidation of eukaryotic elongation factor-2 contact sites within the catalytic domain of Pseudomonas aeruginosa exotoxin A. Biochem. J. 379, 563-572. doi: 10.1042/BJ20031731
64. Zerial, M., and McBride, H. (2001). Rab proteins as membrane organizers. Nat. Rev. Mol. Cell Biol. 2, 107-117. doi: 10.1038/35052055